{"id":13492,"date":"2026-07-06T10:45:45","date_gmt":"2026-07-06T08:45:45","guid":{"rendered":"https:\/\/orsingher.com\/stefano-giberti-alla-conference-bleue-di-londra\/"},"modified":"2026-07-07T10:48:04","modified_gmt":"2026-07-07T08:48:04","slug":"stefano-giberti-alla-conference-bleue-di-londra","status":"publish","type":"post","link":"https:\/\/orsingher.com\/en\/stefano-giberti-alla-conference-bleue-di-londra\/","title":{"rendered":"Stefano Giberti at the Conf\u00e9rence Bleue meeting in London"},"content":{"rendered":"<p class=\"font-claude-response-body break-words whitespace-normal\">On Friday 3 July, Stefano Giberti took part in the Conf\u00e9rence Bleue meeting held in London. Conf\u00e9rence Bleue is a leading European network of law firms specialising in the life sciences and healthcare sector, with over twenty years of experience assisting clients on cross-border regulatory, IP and competition matters.<\/p>\n<p class=\"font-claude-response-body break-words whitespace-normal\">The meeting brought together practitioners from across Europe to exchange views on the latest legal and regulatory developments affecting the pharmaceutical, medtech and healthcare industries \u2014 a valuable opportunity to strengthen international cooperation and share best practices.<\/p>\n<div style=\"width: 1080px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-13492-1\" width=\"1080\" height=\"1080\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"https:\/\/orsingher.com\/wp-content\/uploads\/2026\/07\/Conference-Bleue.mp4?_=1\" \/><a href=\"https:\/\/orsingher.com\/wp-content\/uploads\/2026\/07\/Conference-Bleue.mp4\">https:\/\/orsingher.com\/wp-content\/uploads\/2026\/07\/Conference-Bleue.mp4<\/a><\/video><\/div>\n","protected":false},"excerpt":{"rendered":"<p>On Friday 3 July, Stefano Giberti took part in the Conf\u00e9rence Bleue meeting held in London. Conf\u00e9rence Bleue is a leading European network of law firms specialising in the life sciences and healthcare sector, with over twenty years of experience assisting clients on cross-border regulatory, IP and competition matters. The meeting brought together practitioners from [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[63],"tags":[],"class_list":["post-13492","post","type-post","status-publish","format-standard","hentry","category-news-en-2"],"acf":[],"_links":{"self":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/13492","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/comments?post=13492"}],"version-history":[{"count":0,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/posts\/13492\/revisions"}],"wp:attachment":[{"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/media?parent=13492"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/categories?post=13492"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/orsingher.com\/en\/wp-json\/wp\/v2\/tags?post=13492"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}